This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Eli Lilly has finalized a massive $2.75 billion agreement with Insilico Medicine to leverage generative AI for drug discovery. This landmark deal, including $115 million in upfront payments, signals a ma
